Did you know that a medication for diabetes may also help protect yourkidneys?GLP-1medications, known for helping with weight loss, offer surprising benefits for people withkidneydisease. Dr. Holly Kramer, a nephrologist orkidneydoctor, explains how these medications work and why they matter forkidneyhealth.
Glucagon-like peptide-1 (GLP-1) receptor agonists are incretin-based therapies initially developed for the management of type 2 diabetes. In addition to improving glycemic control and promoting weight loss, these agents have demonstrated cardiovascular and potential renal benefits. This review explores the mechanisms by whichGLP-1receptor agonists may exert renoprotectiveeffects, including ...
Furthermore, visual representations like the one above help us fully grasp the concept of Diabetic Kidney Disease Glp-1 Therapy Effects.
GLP-1receptor agonists are highly effective medicines for treating diabetes and obesity, helping patients lower blood sugar, lose weight, and improve heart andkidneyhealth. However, their growing popularity has also revealed important challenges, including sideeffects, drug shortages, high costs, and misuse for cosmetic weight loss. To ensure safe and fair use, these treatments should be ...
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are highly effective in reducing glycemia in patients with type 2 diabetes (T2D). These medications effectively reduce cardiovascular (CV) risk in patients with T2D and established CVdiseaseor with multiple risk factors. In addition, treatment withGLP-1RA may exert protectiveeffectson thediabetickidney. Herein, we summarize the ...
A randomized phase 2b trial examined theeffectsof the glucagon-like peptide-1 and glucagon receptor agonist cotadutide onkidneyoutcomes in patients withdiabetickidneydisease.
